NorthWest Biotherapeutics Inc (NWBO)

[abeta]

About 200,000 people die each year from a glioblastoma in the world, including nearly 15,000 in Europe and 9,000 in the United States.

(surgery is possible in 50% to 70% of patients, depending on the geographical area),

The efficacy of this first-line treatment varies according to the biological status of the patients for the EGFRvIII and MGMT genes,

https://www.gliocure.com/en/patients/glioblastoma/#:~:text=About%20200%2C000%20people%20die%20each,9%2C000%20in%20the%20United%20States.

In Europe, approximately 15 000 people die annually from glioblastoma.
https://projects.research-and-innovation.ec.europa.eu/en/horizon-magazine/shining-light-aggressive-brain-cancer